Justice Department Requires CVS and Aetna to Divest Aetna’s Medicare Individual Part D Prescription Drug Plan Business to Proceed With Merger
"Today's settlement resolves competition concerns posed by this transaction and preserves competition in the sale of Medicare Part D prescription drug plans for individuals," said Assistant Attorney General
The Department's
CVS, the nation's largest retail pharmacy chain, and
According to the Department's complaint, the combination of CVS, which markets its Medicare Part D individual prescription drug plans under the "SilverScript" brand, and
Under the terms of the proposed settlement,
The settlement also includes, consistent with other settlements, several provisions designed to improve the effectiveness of the decree and the Division's future ability to enforce it.
CVS, headquartered in
As required by the Tunney Act, the proposed consent decree, along with the Department's competitive impact statement, will be published in the
Hotel Putnam fire investigation closes with no known suspects
Home Mortgage Disclosure Act (HMDA): Bureau of Consumer Financial Protection Interpretive and Procedural Rule on Partial Exemptions From HMDA Requirements
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News